Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > CIDY vs THTX..

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Dec 21, 2020 12:01pm

167 Views

Post# 32152983

RE:RE:RE:RE:RE:RE:CIDY vs THTX..

They have managed to produce "credibility" with uninformed retail investors and there are plenty of those types of nvestors right now as we are likely at the peak of a speculative frenzy where such crazy things happen alot. It is basically nuts but the market loses its mind like this every 20 years or so.